Report cover image

Hemodialysis Vascular Grafts Market Report and Forecast 2025-2034

Published Jul 27, 2025
Length 350 Pages
SKU # EMAR20319686

Description

The global hemodialysis vascular grafts market size was valued at USD 284.78 Million in 2024, driven by the increasing geriatric population across the globe. The market size is anticipated to grow at a CAGR of 5.20% during the forecast period of 2025-2034 to achieve a value of USD 472.79 Million by 2034.

Hemodialysis Vascular Grafts: Introduction

Arteriovenous (AV) graft is widely used for hemodialysis. The usual placement of graft is in the arm, but it can also be placed in the leg depending upon the situation. An AV graft is the connection of a vein and an artery that utilizes a hollow, synthetic tube (the actual “graft”). This connection enables high blood flow, high pressure artery through the graft and into the low flow, low pressure vein.  Due to which, blood flow through the graft provides a flow rate delivering sufficient blood to provide an appropriate hemodialysis treatment.

Global Hemodialysis Vascular Grafts Market Analysis

The market for hemodialysis vascular grafts has been experiencing significant growth supported by various factors and is expected to steadily grow in coming years as well. The factors such as increasing technological advancement in hemodialysis therapy are majorly influencing the market growth. The advancements such as bioartificial kidneys, hemodiafiltration, wearable artificial kidneys, and portable machines are influencing the market and hemodialysis adoption by patients and healthcare professionals.

The key players are heavily investing in the research and development activities that are inclined towards creating more advanced technological equipment, medicinal drugs and therapies to treat chronic kidney diseases which is expected to further propel the global hemodialysis vascular grafts market growth. For example, Kidney Health Initiative and Kidney X: The Kidney Innovation Accelerator, as well as The Advancing American Kidney Health Initiative are collaborating to develop new therapies which could potentially customize the treatment of end-stage renal disease ESRD.  The continuous research and development activities by key players in the market are directly contributing to the market expansion as well. For example, Xeltis is a key player targeted towards developing transformative implants to provide solutions to the patients of such chronic diseases has presented highly encouraging six-month data from its first-in-human (FIH) aXess vascular graft trial (NCT04898153). The data exhibited high patency rates (80% primary patency, 95% primary assisted patency, 100% secondary patency). A 0% infection rate and low re-intervention rates were encountered at the six months duration, resulting in a highly favorable safety profile.

Global Hemodialysis Vascular Grafts Market Segmentations

Hemodialysis Vascular Grafts Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Product
  • Synthetic Grafts
  
  • Expanded Polytetrafluoroethylene (ePTFE)

  •   
  • Polyethylene Terephthalate (PET)
    • Biological Grafts
      
  • Human Saphenous and Umbilical Veins

  •   
  • Autologous Vein Grafts

  •   
  • Bovine Grafts

  •   
  • Porcine Grafts

  •   
  • Others

  • Market Breakup by Diameters
    • Small Diameter Grafts (4 to 6 mm)
    • Large Diameter Grafts (6 to 10 mm)
    Market Breakup by Configuration
    • Straight Grafts
    • Loop Grafts
    Market Breakup by End Use
    • Hospitals
    • Dialysis Centers
    • Ambulatory Surgical Centers (ASCs)
    • Others
    Market Breakup by Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
    Global Hemodialysis Vascular Grafts Market Overview

    The increasing prevalence of chronic kidney diseases worldwide is propelling the market growth. According to the National Kidney Foundation, nearly 10% of the global population is affected by chronic kidney disease (CKD) accounting for millions of deaths yearly. The increase in geriatric population globally is also a major factor, adding further growth to the global hemodialysis vascular grafts market share. With increasing age, people get more susceptible to kidney diseases due to various factors, such as cardiovascular diseases, hypertension, and diabetes, among others.

    North America has been leading the global market and is expected to lead the global market for the forecast period as well. This growth of the region is expected to be driven by the presence of geriatric population, large patient pool suffering from chronic kidney diseases due to factors such as adoption of sedentary lifestyle, including alcohol consumption, and unhealthy dietary habits, among others.

    Hemodialysis Vascular Grafts Market: Competitor Landscape

    The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
    • W. L. Gore & Associates, Inc.,
    • C. R. Bard, Inc.
    • Vascudyne, Inc.
    • LeMaitre
    • Getinge AB,
    • VASCULAR GENESIS,
    • InnAVasc Medical, Inc.
    • CryoLife, Inc.
    • Merit Medical Systems
    • BIOVIC Sdn Bhd.
    *Please Note:* The report will take 5 business days to complete, after order confirmation.

    Table of Contents

    350 Pages
    1 Preface
    1.1 Objectives of the Study
    1.2 Key Assumptions
    1.3 Report Coverage – Key Segmentation and Scope
    1.4 Research Methodology
    2 Executive Summary
    3 Global Hemodialysis Vascular Grafts Market Overview
    3.1 Global Hemodialysis Vascular Grafts Market Historical Value (2018-2024)
    3.2 Global Hemodialysis Vascular Grafts Market Forecast Value (2025-2034)
    4 Global Hemodialysis Vascular Grafts Market Landscape
    4.1 Global Hemodialysis Vascular Grafts Developers Landscape
    4.1.1 Analysis by Year of Establishment
    4.1.2 Analysis by Company Size
    4.1.3 Analysis by Region
    4.2 Global Hemodialysis Vascular Grafts Product Landscape
    4.2.1 Analysis by Product
    4.2.2 Analysis by Diameter
    4.2.3 Analysis by Configuration
    5 Global Hemodialysis Vascular Grafts Market Dynamics
    5.1 Market Drivers and Constraints
    5.2 SWOT Analysis
    5.3 Porter’s Five Forces Model
    5.4 Key Demand Indicators
    5.5 Key Price Indicators
    5.6 Industry Events, Initiatives, and Trends
    5.7 Value Chain Analysis
    6 Global Hemodialysis Vascular Grafts Market Segmentation
    6.1 Global Hemodialysis Vascular Grafts Market by Product
    6.1.1 Market Overview
    6.1.2 Synthetic Grafts
    6.1.2.1 Expanded Polytetrafluoroethylene (ePTFE)
    6.1.2.2 Polyethylene Terephthalate (PET)
    6.1.3 Biological Grafts
    6.1.3.1 Human Saphenous and Umbilical Veins
    6.1.3.2 Autologous Vein Grafts
    6.1.3.3 Bovine Grafts
    6.1.3.4 Porcine Grafts
    6.1.3.5 Others
    6.2 Global Hemodialysis Vascular Grafts Market by Diameters
    6.2.1 Market Overview
    6.2.2 Small Diameter Grafts (4 to 6 mm)
    6.2.3 Large Diameter Grafts (6 to 10 mm)
    6.3 Global Hemodialysis Vascular Grafts Market by Configuration
    6.3.1 Market Overview
    6.3.2 Straight Grafts
    6.3.3 Loop Grafts
    6.4 Global Hemodialysis Vascular Grafts Market by End Use
    6.4.1 Market Overview
    6.4.2 Hospitals
    6.4.3 Dialysis Centers
    6.4.4 Ambulatory Surgical Centers (ASCs)
    6.4.5 Others
    6.5 Global Hemodialysis Vascular Grafts Market by Region
    6.5.1 Market Overview
    6.5.2 North America
    6.5.3 Europe
    6.5.4 Asia Pacific
    6.5.5 Latin America
    6.5.6 Middle East and Africa
    7 North America Hemodialysis Vascular Grafts Market
    7.1 Market Share by Country
    7.2 United States of America
    7.3 Canada
    8 Europe Hemodialysis Vascular Grafts Market
    8.1 Market Share by Country
    8.2 United Kingdom
    8.3 Germany
    8.4 France
    8.5 Italy
    8.6 Others
    9 Asia Pacific Hemodialysis Vascular Grafts Market
    9.1 Market Share by Country
    9.2 China
    9.3 Japan
    9.4 India
    9.5 ASEAN
    9.6 Australia
    9.7 Others
    10 Latin America Hemodialysis Vascular Grafts Market
    10.1 Market Share by Country
    10.2 Brazil
    10.3 Argentina
    10.4 Mexico
    10.5 Others
    11 Middle East and Africa Hemodialysis Vascular Grafts Market
    11.1 Market Share by Country
    11.2 Saudi Arabia
    11.3 United Arab Emirates
    11.4 Nigeria
    11.5 South Africa
    11.6 Others
    12 Patent Analysis
    12.1 Analysis by Type of Patent
    12.2 Analysis by Publication year
    12.3 Analysis by Issuing Authority
    12.4 Analysis by Patent Age
    12.5 Analysis by CPC Analysis
    12.6 Analysis by Patent Valuation
    12.7 Analysis by Key Players
    13 Grants Analysis
    13.1 Analysis by year
    13.2 Analysis by Amount Awarded
    13.3 Analysis by Issuing Authority
    13.4 Analysis by Grant Application
    13.5 Analysis by Funding Institute
    13.6 Analysis by NIH Departments
    13.7 Analysis by Recipient Organization
    14 Funding Analysis
    14.1 Analysis by Funding Instances
    14.2 Analysis by Type of Funding
    14.3 Analysis by Funding Amount
    14.4 Analysis by Leading Players
    14.5 Analysis by Leading Investors
    14.6 Analysis by Geography
    15 Partnership and Collaborations Analysis
    15.1 Analysis by Partnership Instances
    15.2 Analysis by Type of Partnership
    15.3 Analysis by Leading Players
    15.4 Analysis by Geography
    16 Regulatory Framework
    16.1 Regulatory Overview
    16.1.1 US FDA
    16.1.2 EU EMA
    16.1.3 INDIA CDSCO
    16.1.4 JAPAN PMDA
    16.1.5 Others
    17 Supplier Landscape
    17.1 W. L. Gore & Associates, Inc.
    17.1.1 Financial Analysis
    17.1.2 Product Portfolio
    17.1.3 Demographic Reach and Achievements
    17.1.4 Mergers and Acquisition
    17.1.5 Certifications
    17.2 C. R. Bard, Inc.
    17.2.1 Financial Analysis
    17.2.2 Product Portfolio
    17.2.3 Demographic Reach and Achievements
    17.2.4 Mergers and Acquisition
    17.2.5 Certifications
    17.3 Vascudyne, Inc.
    17.3.1 Financial Analysis
    17.3.2 Product Portfolio
    17.3.3 Demographic Reach and Achievements
    17.3.4 Mergers and Acquisition
    17.3.5 Certifications
    17.4 LeMaitre
    17.4.1 Financial Analysis
    17.4.2 Product Portfolio
    17.4.3 Demographic Reach and Achievements
    17.4.4 Mergers and Acquisition
    17.4.5 Certifications
    17.5 Getinge AB
    17.5.1 Financial Analysis
    17.5.2 Product Portfolio
    17.5.3 Demographic Reach and Achievements
    17.5.4 Mergers and Acquisition
    17.5.5 Certifications
    17.6 VASCULAR GENESIS
    17.6.1 Financial Analysis
    17.6.2 Product Portfolio
    17.6.3 Demographic Reach and Achievements
    17.6.4 Mergers and Acquisition
    17.6.5 Certifications
    17.7 InnAVasc Medical, Inc.
    17.7.1 Financial Analysis
    17.7.2 Product Portfolio
    17.7.3 Demographic Reach and Achievements
    17.7.4 Mergers and Acquisition
    17.7.5 Certifications
    17.8 CryoLife, Inc.
    17.8.1 Financial Analysis
    17.8.2 Product Portfolio
    17.8.3 Demographic Reach and Achievements
    17.8.4 Mergers and Acquisition
    17.8.5 Certifications
    17.9 Merit Medical Systems
    17.9.1 Financial Analysis
    17.9.2 Product Portfolio
    17.9.3 Demographic Reach and Achievements
    17.9.4 Mergers and Acquisition
    17.9.5 Certifications
    17.10 BIOVIC Sdn Bhd.
    17.10.1 Financial Analysis
    17.10.2 Product Portfolio
    17.10.3 Demographic Reach and Achievements
    17.10.4 Mergers and Acquisition
    17.10.5 Certifications
    18 Global Hemodialysis Vascular Grafts Market - Distribution Model (Additional Insight)
    18.1 Overview
    18.2 Potential Distributors
    18.3 Key Parameters for Distribution Partner Assessment
    19 Key Opinion Leaders (KOL) Insights (Additional Insight)
    20 Company Competitiveness Analysis (Additional Insight)
    20.1 Very Small Companies
    20.2 Small Companies
    20.3 Mid-Sized Companies
    20.4 Large Companies
    20.5 Very Large Companies
    21 Payment Methods (Additional Insight)
    21.1 Government Funded
    21.2 Private Insurance
    21.3 Out-of-Pocket
    How Do Licenses Work?
    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.